Abstract
Cancer is a leading cause of mortality worldwide. Cancer arises due to a series of somatic mutations that accumulate within the nucleus of a cell which enable the cell to proliferate in an unregulated manner. These mutations arise as a result of both endogenous and exogenous factors. Genes that are commonly mutated in cancer cells are involved in cell cycle regulation, growth and proliferation. It is known that both nature and nurture play important roles in cancer development through complex gene-environment interactions; however, the exact mechanism of these interactions in carcinogenesis is presently unclear. Key environmental factors that play a role in carcinogenesis include smoking, UV light and oncoviruses. Angiogenesis, inflammation and altered cell metabolism are important factors in carcinogenesis and are influenced by both genetic and environmental factors. Although the exact mechanism of nature-nurture interactions in solid tumour formation are not yet fully understood, it is evident that neither nature nor nurture can be considered in isolation. By understanding more about gene-environment interactions, it is possible that cancer mortality could be reduced.
Similar content being viewed by others
References
Stewart BW, Wild CP (eds) (2014) World cancer report. International agency for research on cancer, Lyon
Hanahan D, Weinberg RA (2000) The hallmarks of cancer. Cell 100(1):57–70
Hanahan D (2011) Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144(5):646–674
Cancer Research UK (2013) How many different types of cancer are there? [internet] http://www.cancerresearchuk.org/about-cancer/cancers-in-general/cancer-questions/how-many-different-types-of-cancer-are-there. Accessed 22 February 2015
Brennan P (2002) Gene-environment interaction and aetiology of cancer: what does it mean and how can we measure it? Carcinogenesis 23(3):381–387
Milne AN, Carneiro F, O’Morain C, Offerhaus GJA (2009) Nature meets nurture: molecular genetics of gastric Cancer. Hum Genet 126:615–628
Perera FP (1997) Environment and cancer: who are susceptible? Science 278(5340):1068–1073
Stratton MR, Campbell PJ, Futreal PA (2009) The cancer genome. Nature 458:719–724
Weinstein IB (1988) The origins of human cancer: molecular mechanisms of carcinogenesis and their implications for cancer prevention and treatment-twenty-seventh G.H.A. Clowes memorial award lecture. Cancer Res 48(15):4135–4143
Weinberg RA (2014) The biology of cancer, 2nd edn. Garland Science, New York
Hoffman D, Hecht SS, Wynder EL (1983) Tumor promoters and cocarcinogens in tobacco carcinogenesis. Environ Health Perspect 50:247–257
Rundhaug JE, Fischer SM (2010) Molecular mechanisms of mouse skin tumor promotion. Cancers (Basel) 2(2):436–482
Marquardt B, Frith D, Stabel S (1994) Signalling from TPA to MAP kinase requires protein kinase C, Raf and MEK: reconstitution of the signalling pathway in vitro. Oncogene 9(11):3213–3218
Grivennikov SI, Greten FR, Karin M (2010) Immunity, Inflammation and Cancer. Cell 140(6):883–899
Fidler IJ (2003) The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited. Nat Rev Cancer 3(6):453–458
Friedl P, Alexander S (2011) Cancer invasion and the microenvironment: plasticity and reciprocity. Cell 147(5):992–1009
Bernards R, Weinberg RA (2002) A progression puzzle. Nature 418(6900):823
Bozic I, Antal T, Ohtsuki H, Carter H, Kim D, Chen S, et al. (2010) Accumulation of driver and passenger mutations during tumor progression. Proc Natl Acad Sci U S A 107:18545–18550
Pao W, Girard N (2011) New driver mutations in non-small-cell lung cancer. Lancet Oncol 12(2):175–180
Kandoth C, McLellan MD, Vandin F, Ye K, Niu B, Lu C, et al. (2013) Mutational landscape and significance across 12 major cancer types. Nature 502:333–339
Sloan FA, Gelband H (2007) Cancer control in low- and middle-income countries. Institute of medicine (US) committee on cancer control in low- and middle-income countries national academies press (US), Washington DC http://wwwncbinlmnihgov/books/NBK54030/. Accessed 23 February 2015
Hoffman MA, Ohh M, Yang H, Klco JM, Ivan M, Kaelin WG Jr (2001) Von Hippel-Lindau protein mutants linked to type 2C VHL disease preserve the ability to downregulate HIF. Hum Mol Genet 10(10):1019–1027
Park M, Lee S (2003) Cell Cycle and Cancer. J Biochem Mol Biol 36(1):60–65
Rivlin N, Brosh R, Oren M, Rotter V (2011) Mutations in the p53 tumor suppressor gene important milestones at the various steps of tumorigenesis. Genes Cancer 2(4):466–474
Knudson AG Jr (1971) Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci U S A 68:820–823
Kufe DW, Pollock RE, Weichselbaum RR, et al (eds) (2003) Holland-Frei cancer medicine, 6th edn. BC Decker, Hamilton (ON) http://www.ncbi.nlm.nih.gov/books/NBK12354/. Accessed 24 February 2015
Boffetta P, Nyberg F (2003) Contribution of environmental factors to cancer risk. Br Med Bull 68:71–94
Yokota J (2000) Tumour progression and metastasis. Carcinogenesis 21(3):497–503
Doll R, Hill AB (1950) Smoking and carcinoma of the lung. Br Med J 2(4682):739–748
Carbone D (1992) Smoking and cancer. Am J Med 93(1):S13–S17
Heck DE, Vetrano AM, Mariano TM, Laskin JD (2003) UVB light stimulates production of reactive oxygen species: unexpected role for catalase. J Biol Chem 278(25):22432–22436
Hodis E, Watson IR, Kryukov GV, Arold ST, Imielinksi M, Theurillat J, et al. (2012) A Landscape of Driver Mutations in Melanoma. Cell 150(2):251–263
Moore PS, Chang Y (2010) Why do viruses cause cancer? Highlights of the first century of human tumour virology. Nat Rev Cancer 10(12):878–889
Talbot SJ, Crawford DH (2004) Viruses and tumours – an update. Eur J Cancer 40(13):1998–2005
Polk D, Peek R (2010) Helicobacter pylori: gastric cancer and beyond. Nat Rev Cancer 10(6):403–414
Folkman J (2002) Role of Angiogenesis in tumor growth and Metastasis. Semin Oncol 29(6 Suppl 16):15–18
Ferrara N (2005) VEGF as a therapeutic target in cancer. Oncology 69(Suppl 3):11–16
Yang SR, Chida AS, Bauter MR, Shafiq N, Seweryniak K, Maggirwar SB, et al. (2006) Cigarette smoke induces proinflammatory cytokine release by activation of NF-κB and posttranslational modifications of histone deacetylase in macrophages. Am J Physiol Lung Cell Mol Physiol 291(1):L46–L57
Karin M, Greten FR (2005) NF-κB: linking inflammation and immunity to cancer development and progression. Nat Rev Immunol 5(10):749–759
Balkwill F (2006) TNF-α in promotion and progression of cancer. Cancer Metastasis Rev 25(4):409–416
Lee YS, Choi I, Ning Y, Kim NY, Khatchadourian V, Yang D, et al. (2012) Interleukin-8 and its receptor CXCR2 in the tumour microenvironment promote colon cancer growth, progression and metastasis. Br J Cancer 106(11):1833–1841
Han J, Haiman C, Niu T, Guo Q, Cox DG, Willett WC, et al. (2009) Genetic variation in DNA repair pathway genes and premenopausal breast cancer risk. Breast Cancer Res Treat 115(3):613–622
Traynor BJ, Singleton AB (2010) Nature versus Nurture: Death of a Dogma, and the Road Ahead. Neuron 68(2):196–200
Author information
Authors and Affiliations
Corresponding author
Additional information
IJ Hyndman was affiliated with the University of Glasgow at the time of writing.
Rights and permissions
About this article
Cite this article
Hyndman, I.J. Review: the Contribution of both Nature and Nurture to Carcinogenesis and Progression in Solid Tumours. Cancer Microenvironment 9, 63–69 (2016). https://doi.org/10.1007/s12307-016-0183-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12307-016-0183-4